The fine line : Chris Worrall and Sandra Mapara discuss the pay-for-delay case against drug firms Aspen, Amilco and Tiofarma that resulted in fines totalling £2.3m.
The fine line : Chris Worrall and Sandra Mapara discuss the pay-for-delay case against drug firms Aspen, Amilco and Tiofarma that resulted in fines totalling £2.3m.